» Articles » PMID: 29058704

Nuclear Functions of NME Proteins

Overview
Journal Lab Invest
Specialty Pathology
Date 2017 Oct 24
PMID 29058704
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The NME family of proteins is composed of 10 isoforms, designated NME1-10, which are diverse in their enzymatic activities and patterns of subcellular localization. Each contains a conserved domain associated with a nucleoside diphosphate kinase (NDPK) function, although not all are catalytically active. Several of the NME isoforms (NME1, NME5, NME7, and NME8) also exhibit a 3'-5' exonuclease activity, suggesting roles in DNA proofreading and repair. NME1 and NME2 have been shown to translocate to the nucleus, although they lack a canonical nuclear localization signal. Binding of NME1 and NME2 to DNA does not appear to be sequence-specific in a strict sense, but instead is directed to single-stranded regions and/or other non-B-form structures. NME1 and NME2 have been identified as potential canonical transcription factors that regulate gene transcription through their DNA-binding activities. Indeed, the NME1 and NME2 isoforms have been shown to regulate gene expression programs in a number of cellular settings, and this regulatory function has been proposed to underlie their well-recognized ability to suppress the metastatic phenotype of cancer cells. Moreover, NME1 and, more recently, NME3, have been implicated in repair of both single- and double-stranded breaks in DNA. This suggests that reduced expression of NME proteins could contribute to the genomic instability that drives cancer progression. Clearly, a better understanding of the nuclear functions of NME1 and possibly other NME isoforms could provide critical insights into mechanisms underlying malignant progression in cancer. Indeed, clinical data indicate that the subcellular localization of NME1 may be an important prognostic marker in some cancers. This review summarizes putative functions of nuclear NME proteins in DNA binding, transcription, and DNA damage repair, and highlights their possible roles in cancer progression.

Citing Articles

APOE genotype and brain amyloid are associated with changes in the plasma proteome in elderly subjects without dementia.

Philippi S, Bp K, Raj T, Castellano J Ann Clin Transl Neurol. 2024; 12(2):366-382.

PMID: 39689057 PMC: 11822792. DOI: 10.1002/acn3.52250.


Nuclear IMPDH2 controls the DNA damage response by modulating PARP1 activity.

Espinar L, Garcia-Cao M, Schmidt A, Kourtis S, Ganez Zapater A, Aranda-Vallejo C Nat Commun. 2024; 15(1):9515.

PMID: 39532854 PMC: 11557828. DOI: 10.1038/s41467-024-53877-z.


Tumor suppressor NME1/NM23-H1 modulates DNA binding of NF-κB RelA.

Shahabi S, Maurya M, Subramaniam S, Ghosh G Res Sq. 2024; .

PMID: 39483891 PMC: 11527346. DOI: 10.21203/rs.3.rs-5242004/v1.


Nme8 is essential for protection against chemotherapy drug cisplatin-induced male reproductive toxicity in mice.

Zhu H, Wang H, Wang D, Liu S, Sun X, Qu Z Cell Death Dis. 2024; 15(10):730.

PMID: 39368984 PMC: 11457495. DOI: 10.1038/s41419-024-07118-2.


Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells.

Cheng C, Katoch P, Zhong Y, Higgins C, Moredock M, Chang M Int J Mol Sci. 2024; 25(18).

PMID: 39337350 PMC: 11432080. DOI: 10.3390/ijms25189863.


References
1.
Marioni G, Ottaviano G, Lionello M, Lora L, Lovato A, Staffieri C . Nm23-H1 nuclear expression is associated with a more favourable prognosis in laryngeal carcinoma: univariate and multivariate analysis. Histopathology. 2012; 61(6):1057-64. DOI: 10.1111/j.1365-2559.2012.04331.x. View

2.
Cheng S, Alfonso-Jaume M, Mertens P, Lovett D . Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1). Biochem J. 2002; 366(Pt 3):807-16. PMC: 1222814. DOI: 10.1042/BJ20020202. View

3.
Curtis C, Likhite V, McLeod I, Yates J, Nardulli A . Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression. Cancer Res. 2007; 67(21):10600-7. DOI: 10.1158/0008-5472.CAN-07-0055. View

4.
Zhang Q, McCorkle J, Novak M, Yang M, Kaetzel D . Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Int J Cancer. 2010; 128(1):40-50. PMC: 2946830. DOI: 10.1002/ijc.25307. View

5.
Yadav V, Thakur R, Eckloff B, Baral A, Singh A, Halder R . Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity. Nucleic Acids Res. 2014; 42(15):9602-11. PMC: 4150765. DOI: 10.1093/nar/gku596. View